(Q36641925)

15 August 2017

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations (English)

1 reference

Isabelle Janoueix-Lerosey

15 August 2017

38

Isabelle Janoueix-Lerosey

0 references

Peter van Sluis

30

Peter van Sluis

0 references

Valérie Combaret

Valérie Combaret

0 references

Trevor J Pugh

Trevor J Pugh

15

0 references

Jan Koster

Jan Koster

4

0 references

Rogier Versteeg

Rogier Versteeg

43

0 references

Thomas F Eleveld

Thomas F Eleveld

1

0 references

Leo Colmet Daage

Leo Colmet Daage

5

0 references

Olivier Delattre

Olivier Delattre

41

0 references

Malcolm A Smith

Malcolm A Smith

25

0 references

Ellen van der Schoot

33

C Ellen van der Schoot

1 reference

15 August 2017

40

Huib N Caron

1 reference

15 August 2017

22

Julie M Gastier-Foster

1 reference

15 August 2017

35

Johannes H Schulte

1 reference

15 August 2017

Gudrun Schleiermacher

44

Gudrun Schleiermacher

1 reference

15 August 2017

11

Eve Lapouble

1 reference

15 August 2017

14

Jean Michon

1 reference

15 August 2017

46

John M Maris

1 reference

15 August 2017

13

Patricia Legoix-Né

1 reference

15 August 2017

21

Arlene Naranjo

1 reference

15 August 2017

23

Michael D Hogarty

1 reference

15 August 2017

2

Derek A Oldridge

1 reference

15 August 2017

10

Mathieu Chicard

1 reference

15 August 2017

24

Shahab Asgharzadeh

1 reference

15 August 2017

34

Ellen M Westerhout

1 reference

15 August 2017

18

Edward F Attiyeh

1 reference

15 August 2017

16

Lori S Hart

1 reference

15 August 2017

6

Sharon J Diskin

1 reference

15 August 2017

Danny A Zwijnenburg

28

0 references

Godelieve A. M. Tytgat

36

Godelieve A Tytgat

1 reference

15 August 2017

Virginie Bernard

3

1 reference

15 August 2017

Linda Schild

7

1 reference

15 August 2017

Nadia Bessoltane Bentahar

8

1 reference

15 August 2017

Angela Bellini

9

1 reference

15 August 2017

JulieAnn Rader

17

1 reference

15 August 2017

Jun S Wei

19

1 reference

15 August 2017

Shile Zhang

20

1 reference

15 August 2017

Jaime M Guidry Auvil

26

1 reference

15 August 2017

Thomas B K Watkins

27

1 reference

15 August 2017

Marli E Ebus

29

1 reference

15 August 2017

Anne Hakkert

31

1 reference

15 August 2017

Esther van Wezel

32

1 reference

15 August 2017

M Emmy M Dolman

37

1 reference

15 August 2017

Daniela S Gerhard

39

1 reference

15 August 2017

Javed Khan

42

1 reference

15 August 2017

Jan J Molenaar

45

1 reference

15 August 2017

language of work or name

English

0 references

publication date

29 June 2015

1 reference

15 August 2017

1 reference

15 August 2017

47

1 reference

15 August 2017

8

1 reference

15 August 2017

864-871

1 reference

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Emergence of new ALK mutations at relapse of neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

PyClone: statistical inference of clonal population structure in cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

The genetic landscape of high-risk neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Children's Oncology Group's 2013 blueprint for research: neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

An integrated map of genetic variation from 1,092 human genomes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

DELLY: structural variant discovery by integrated paired-end and split-read analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Absolute quantification of somatic DNA alterations in human cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Systematic identification of genomic markers of drug sensitivity in cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Patient-oriented gene set analysis for cancer mutation data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Circos: an information aesthetic for comparative genomics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Fast and accurate short read alignment with Burrows-Wheeler transform

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Activating mutations in ALK provide a therapeutic target in neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Chromosome 1p and 11q deletions and outcome in neuroblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

A census of human cancer genes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Recent advances in neuroblastoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775079

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

21 October 2018

1 reference

12 December 2020

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

12 December 2020

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

12 December 2020

Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97

1 reference

12 December 2020

Accumulation of Segmental Alterations Determines Progression in Neuroblastoma

1 reference

12 December 2020

Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials

1 reference

12 December 2020

Identifiers

DOI

10.1038/NG.3333

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

26121087

1 reference